{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GLAPY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLAPY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAPY\",,,,,undefined,":{"symbol":"GLAPY","market":"US","secType":"STK","nameCN":"Glanbia Plc","latestPrice":98.24,"timestamp":1771621200000,"preClose":99,"halted":0,"volume":710,"delay":15,"changeRate":-0.007676767676767729,"floatShares":37730856,"shares":50169674,"eps":3.122495,"marketStatus":"Pre-Mkt","change":-0.76,"latestTime":"02-20 16:00:00 EST Delay","open":98.24,"high":98.24,"low":98.24,"amount":69750.4,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":3.122495,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771857000000},"marketStatusCode":1,"adr":0,"adrRate":5,"exchange":"PINK LIMITED","adjPreClose":98.24,"volumeRatio":154.34614841143033},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAPY\",,,,,undefined,":{"symbol":"GLAPY","floatShares":37730856,"roa":"5.88%","roe":"5.75%","lyrEps":3.160565,"volumeRatio":154.34614841143033,"shares":50169674,"dividePrice":2.216033,"high":98.24,"amplitude":0,"preClose":99,"low":98.24,"week52Low":52.4,"pbRate":"2.40","psRate":"1.25","week52High":99,"institutionHeld":0,"latestPrice":98.24,"eps":3.122495,"divideRate":0.022557,"volume":710,"delay":15,"ttmEps":3.122495,"open":98.24,"prevYearClose":86.47,"prevWeekClose":98.24,"prevMonthClose":99,"prevQuarterClose":86.47,"fiveDayClose":99,"twentyDayClose":87,"sixtyDayClose":86.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAPY\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"GLAPY","amount":1.00509,"announcedDate":"2025-08-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-25","defaultRemindTime":1756128600000,"name":"Glanbia Plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-14","payableDate":"2025-08-25","currency":"USD","dateTimestamp":1756094400000,"payDate":"2025-10-14"},{"date":"2025-03-21","symbol":"GLAPY","amount":1.210943,"announcedDate":"2025-03-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"Glanbia Plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-05-12"},{"market":"US","date":"2025-02-26","symbol":"GLAPY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"","actualEps":null},{"date":"2024-08-26","symbol":"GLAPY","amount":0.861998,"announcedDate":"2024-08-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724679000000,"name":"Glanbia Plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-15","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724644800000,"payDate":"2024-10-15"},{"date":"2024-03-21","symbol":"GLAPY","amount":1.153187,"announcedDate":"2024-03-06","type":"dividend","market":"US","newRecordDate":"2024-03-22","defaultRemindTime":1711027800000,"name":"Glanbia Plc","recordDate":"2024-05-13","payableDate":"2024-03-22","currency":"USD","dateTimestamp":1710993600000,"payDate":"2024-05-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAPY\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-16","recordDate":"2016-03-18","paymentDate":"2016-05-09","value":0.311484,"currency":"USD"},{"executeDate":"2016-08-25","recordDate":"2016-08-29","paymentDate":"2016-10-17","value":0.27188,"currency":"USD"},{"executeDate":"2018-08-23","recordDate":"2018-08-24","paymentDate":"2018-10-15","value":0.525654,"currency":"USD"},{"executeDate":"2019-03-14","recordDate":"2019-03-15","paymentDate":"2019-05-06","value":0.797669,"currency":"USD"},{"executeDate":"2019-08-22","recordDate":"2019-08-23","paymentDate":"2019-10-15","value":0.567206,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAPY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0.8,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":10,"updateTime":1739509200000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAPY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584916813","title":"Glanbia Targets Higher Adjusted Earnings to Reach Growth Ambitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2584916813","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584916813?lang=en_us&edition=fundamental","pubTime":"2025-11-19 16:11","pubTimestamp":1763539860,"startTime":"0","endTime":"0","summary":"Glanbia said it targets higher adjusted earnings per share in the midterm as it sharpens its focus on growth ambitions.The Irish nutrition group on Wednesday said it targets adjusted earnings per share growth in the range of 7% to 11% on a constant currency basis between 2026 and 2028.It also targets return on capital employed in the range of 10% to 13%, with a progressive dividend maintained, it added.In the performance nutrition segment the company aims for annual organic revenue growth of 5% to 7%. It targets a 250 basis point progression in its total three-year earnings before interest, taxes, depreciation, and amortization margin from its 2025 reported base.In health and nutrition, Glanbia targets annual organic revenue growth of between 4% an 6%, as well as an Ebitda margin range of 17% to 19%.In dairy nutrition, an annual Ebitda range of around $150 million to $160 million is targeted.\"We are well-positioned to deliver on our ambition to drive growth and shareholder returns,\" Ch","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","GLAPY"],"gpt_icon":0},{"id":"2581741595","title":"Glanbia's Volume Growth in Optimum Nutrition Confirms Brand Strength -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2581741595","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581741595?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:44","pubTimestamp":1762332240,"startTime":"0","endTime":"0","summary":"0844 GMT - Glanbia's third-quarter double-digit volume growth in optimum nutrition and Isopure products confirms brand strength and category health, Davy Research analyst Cathal Kenny says in a research note. The Irish nutrition group posted volume figures for the business that came ahead of Davy Research's forecast, Kenny says. As a result of the EPS guidance lift to the upper end of the range, Kenny says Davy Research will likely upgrade the company's full-year EPS estimate. Shares trade 4.9% higher at 15.11 euros. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","GLAPY"],"gpt_icon":0},{"id":"2581474511","title":"Glanbia Raises Revenue Guidance for Performance Nutrition Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2581474511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581474511?lang=en_us&edition=fundamental","pubTime":"2025-11-05 15:42","pubTimestamp":1762328520,"startTime":"0","endTime":"0","summary":"Glanbia lifted full-year revenue guidance for its performance nutrition business following strong sequential improvements.The Irish nutrition group on Wednesday raised its revenue outlook for the performance nutrition business to range between growth of  3% to 4% from 2% to 3% previously. Adjusted earnings per share are now expected to be at the upper end of the previous guidance of $1.30 to $1.33, it said.In the first nine months of the year, like-for-like revenue in the performance nutrition business grew 2.5%, excluding brands SlimFast and Body and Fit.Revenue for the whole group in the nine-month period grew 3.3%, with strong growth in the third quarter across all segments, Glanbia said.Optimum nutrition and Isopure brands delivered double-digit volume growth, while health and nutrition, as well as dairy nutrition continued to perform well, it added.\"We continue to progress our groupwide transformation program and completed the sale of noncore brands, SlimFast and Body and Fit, as ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAPY","BK4212"],"gpt_icon":0},{"id":"2540929034","title":"Glanbia Launches Up to $57 Million Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2540929034","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540929034?lang=en_us&edition=fundamental","pubTime":"2025-06-04 15:22","pubTimestamp":1749021720,"startTime":"0","endTime":"0","summary":"Glanbia said it will begin an up to 50 million euro  share buyback as of Wednesday.The nutrition company said it would be buying back ordinary shares through to Dec. 31. The shares to be bought back will be cancelled, the company said.This buyback follows from a previous 50 million euro buyback completed last month.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Glanbia Launches Up to $57 Million Share Buyback","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAPY","BK4212"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}